Nabil A Elshourbagy

Shifa Biomedical Corporation

$7,123,349

Attributed

$8,742,443

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2009–25

$2M$1.5M$1M$500K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$8,742,443 · 7

By mechanism

R44$8,195,876 · 5

R43$546,567 · 2

Top collaborators

Shaker A Mousa4 shared

Most similar at Shifa Biomedical Corporation

Same institution · by research overlap

Sherin S Abdel-Meguid$2,093,739
Arnold T Hagler$574,710

Others in their field

Top investigators on “Risk Factors”

Jeffrey P Krischer · University Of South Florida$393,499,152
Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Gary D Acton · University Of California-Davis$320,373,312
Chanza Baytop · Westat, Inc.$271,217,917
Richard Webby · St. Jude Children'S Research Hospital$180,330,417
John M Lachin · George Washington University$139,236,598

Research focus

Risk FactorsDrug MarketWomanBloodPharmaceutical PreparationsHeart DiseasesTherapeutic TargetDegradation PathwayCardiovascular DiseasesCause Of DeathLeadCholesterolLow-Density LipoproteinsLdl Cholesterol LipoproteinsCholesterol HomeostasisCessation Of LifePlasmaHypercholesterolemiaIn VivoLiverCellsCardiovascular SystemBasePeptide Hydrolases